SBV Journal of Basic, Clinical and Applied Health Science
Volume 6 | Issue 2 | Year 2023

Acute Supraventricular Tachycardia Due to Dengue Infection: A Case Report

Ankush Balasaheb Kolhe

Department of Medicine, Medicover Hospital, Aurangabad, Maharashtra, India

Corresponding Author: Ankush Balasaheb Kolhe, Department of Medicine, Medicover Hospital, Aurangabad, Maharashtra, India, Phone: +91 9975636094, e-mail:

How to cite this article: Kolhe AB. Acute Supraventricular Tachycardia due to Dengue Infection: A Case Report. J Basic Clin Appl Health Sci 2023;6(2):39–42.

Source of support: Nil

Conflict of interest: None

Received on: 05 January 2023; Accepted on: 15 February 2023; Published on: 13 April 2023


Introduction: Electrocardiographic abnormalities were seen in dengue hemorrhagic fever in approximately 30–75% of cases. They are mostly sinus bradycardia and conduction defects. The most common cardiac arrhythmia in practice is supraventricular tachycardia atrial fibrillation (AF). It is mostly seen in structural heart disease. Supraventricular arrhythmia is very rare in dengue fever.

Methods: We present a case of supraventricular tachycardia AF caused by dengue hemorrhagic fever.

Results: Patients with dengue fever need very close electrocardiographic monitoring. All the laboratory results were found to be normal.

Conclusion: Dengue prevalence is high in India. Physicians should be aware.

Keywords: Amiodarone, Atrial fibrillation, Dengue hemorrhagic fever, Supraventricular tachycardia.


Dengue hemorrhagic fever is caused by arbovirus. Its incidence has increased in tropical countries. The main vector is Aedes aegypti, which has spread due to increased urbanization.1 Dengue virus is a single-stranded RNA virus, which exists as four serotypes 1, 2, 3, and 4. Dengue fever is the most severe viral disease, which has been emerging recently in our country.2 The majority of infections have a benign clinical course. But some patients show severe clinical manifestations like bleeding and organ dysfunction. This is due to increased capillary permeability. This causes hypovolemic shock and multiorgan failure.3,4 Electrocardiography changes are common during dengue infection.46 Most of the patients are asymptomatic, but life-threatening cardiac complications are frequent in dengue hemorrhagic fever and dengue shock syndrome.68 These complications can contribute to the mortality caused by dengue infection.6,7 Atrial fibrillation (AF) (supraventricular tachycardia) is the most common type of cardiac arrhythmia seen in routine practice, which is associated with structural heart disease.9,10 We report a case of supraventricular tachycardia AF caused by dengue viral infection.


A 20-year-old female patient was admitted to the hospital with a history of fever, chills, headache, joint pain, and myalgia from 4 to 5 days. She was healthy prior to this admission and didn’t have a history of any cardiac illness, hypothyroidism, or hyperthyroidism. On examination, it was found that she had rash all over her body and she was dehydrated. Her temperature was 101°F, her blood pressure (BP) was 90/60 mm Hg, pulse rate was 54/min, regular and good in volume, and her pulse oximetry showing 98% oxygen saturation. The systemic examination was normal. Her electrocardiogram (ECG)was normal with mild bradycardia (Fig. 1), which was done at the time of admission to the hospital. She was diagnosed as dengue hemorrhagic fever and confirmed by laboratory investigation. Her laboratory parameters are mentioned in Table 1.

Table 1: Laboratory parameters
Routine profile
Parameter Value Reference range
Hemoglobin 13.6 12.0–14.0
White cell count (leukocytes) 2100 4000–10000
Hematocrit 45.0% 35–45
Blood urea 39 17–43
Serum creatinine 1.0 0.72–1.18
Serum sodium 140 meq/L 135–145
Serum potassium 4.0 meq/L 3.5–4.5
Ionic calcium 6.6 mg/dL 6.0–7.0
Rapid malaria test Negative  
Dengue antibody IgG/IgM Positive  
Dengue Ns1 Positive  
ESR 38 <20
ESR, erythrocyte sedimentation rate; IgG, immunoglobulin G antibody; IgM, immunoglobulin M antibody

Fig. 1: Electrocardiogram on admission

She was treated with intravenous normal saline and intravenous paracetamol. She was closely monitored for hematological parameters and any other bleeding tendencies. She was better during hospitalization and was improving. On the fourth day of hospitalization, she complained of palpitations. Her electrocardiogram was done, which showed supraventricular tachycardia AF (Fig. 2). Owing to the reasons, patient was administered first the bolus dose (300 mg) of amiodarone, and then constant infusion (600 mg) over the next 24 hours, intravenous amiodarone started, a 300 mg bolus and 600 mg infusion over 24 hours. After the bolus dose, her ECG was reverted back to normal sinus rhythm.

Fig. 2: Electrocardiogram showing supraventricular tachycardia AF

During this episode, all routine laboratory parameters were rechecked and found within normal limits. Cardiac biomarkers were within the normal limit, the complete thyroid profile was normal, and the serum electrolyte was within the normal limit (Table 2). The echocardiography (Fig. 3) and the chest radiograph were normal (Fig. 4). She was closely monitored for supraventricular tachycardia or any other cardiac arrhythmias during further hospitalization. She didn’t have any ECG changes in further hospitalization and she was comfortable. She was discharged on the seventh day. She was closely monitored to follow-up for electrocardiography changes and the follow-up electrocardiography was normal. All necessary consent and permission were taken from patient and relatives for the submission of reports to this article.

Table 2: Laboratory parameter routine
Parameter Value Reference range
Total bilirubin 1.2 mg/dL 0.2–1.2
Direct/Indirect 0.2/1.0 mg/dL 0.0–0.2/0.2–1.0
Alanine transaminase 36 10.0–30.0
Aspartate aminotransferase 29 10.0–30.0
Prothrombin time 13.8 11–16
International normalized ratio 1.06 0.8–1.2
Lactate dehydrogenase 178 140–270
Serum magnesium 1.5 mg/dL 1.0–1.8
CPK-MB 19 <25
High sensitive troponin I 2.8 <10.0 pg/mL
Thyroid stimulating hormone 2.21 0.35–4.95
HIV/HBsAg/HCV Nonreactive  
CPK-MB, creatine phosphokinase MB; HBsAg, hepatitis surface antigen; HCV, hepatitis C virus; HIV, human immunodeficiency virus; MB, myoglobin

Fig. 3: Echocardiography

Fig. 4: Chest X-ray


Electrocardiographic abnormalities due to dengue infection were common, and they are reported in 34–75% of cases.58 These are mostly sinus bradycardia and conduction abnormalities.5,6 Tachycardia is a normal physiological response to fever, but it is less commonly seen in dengue illness. Supraventricular tachycardia AF is rare during dengue infection.6,7 Our patient had a typical dengue hemorrhagic fever presentation. She had thrombocytopenia, leucopenia, mild hemoconcentration, and positive dengue serological tests that confirmed her dengue illness.58 Her echocardiography did not show any evidence of structural heart abnormalities such as valvular heart disease or cardiomyopathy. There were no other pathological findings in the heart. The need for antiarrhythmic therapy to restore normal sinus rhythm suggests the involvement of subclinical myocarditis even though the biomarkers of cardiac injury were normal.810 Supraventricular tachycardia in our patient was due to subclinical myocarditis caused by the dengue virus.


Dengue prevalence is high in India. Physicians should be aware that supraventricular tachycardia AF may be caused by dengue infection. It is transient and self-limiting but sometimes needs a pharmacological/electric cardioversion. Patients with dengue fever need very close electrocardiographic monitoring.


Ankush Balasaheb Kolhe


1. Gabler DJ, Clark CG. Community involvement in the control of Aedes aegypti. Acta Trop 1996;61:169–179. DOI: 10.1016/0001-706x(95)00103-1.

2. World Health Organization. Comprehensive Guidelines For the Prevention and Control of Dengue and Dengue Hemorrhagic Fever: Revised and expanded edition. India: WHO; 2011. p. 212. Available from:

3. World Health Organization. Dengue Hemorrhagic Fever: Diagnosis, Treatment, Prevention and Control. Vol. 1. Geneva; 1997:24–30. Available from:

4. Khongphatthallayothin A, Chotivitayatarakorn P, Somchit S, Mitprasart A, Sakolsattayadorn S, Thisyakorn C. Mobitz type I second degree AV block during recovery from dengue hemorrhagic fever. Southeast Asian J Trop Med Public Health 2000;31:642–645. PMID: 11414404.

5. Bhatia V, Parida AK, Arora P, Mittal A, Pandey AK, Singh G, et al. Electrocardiographic and echocardiographic findings during the recent outbreak of viral fever in National Capital Region. Indian Heart J 2007;59:360–362. PMID: 19126944.

6. Jayachandran Nair BS, Sudhayakumar N, George R, Jayaprakash VL, Bastian C, Rajesh G, et al. Cardiac manifestations in dengue fever. Indian Heart J 2004;56:585.

7. Yusoff K, Roslawati J, Sinniah M, Khalid B. Electrocardiographic and echocardiographic changes during the acute phase of dengue infection in adults. J HK Coll Cardiol 1993;1:93–96.

8. Chuah SK. Transient ventricular arrhythmia as a cardiac manifestation in dengue hemorrhagic fever: A case report. Singapore Med J 1987;28:569–572. PMID: 3441803.

9. Fuster V, Rydén LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients with Atrial Fibrillation): Developed in collaboration with the North American Society of Pacing and Electrophysiology. J Am Coll Cardiol 2001;38:1231–1266. DOI: 10.1016/s0735-1097(01)01587-x.

10. Snow V, Weiss KB, LeFevre M, McNamara R, Bass E, Green LA, et al. Management of newly detected atrial fibrillation: A clinical practice guideline from the American Academy of Family Physicians and the American College of Physicians. Ann Intern Med 2003;139:1009–1017. DOI: 10.7326/0003-4819-139-12-200312160-00011.

© The Author(s). 2023 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and non-commercial reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.